Two Sigma Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,800
Closed -$362K 4603
2025
Q4
$362K Sell
3,800
-2,200
-37% -$216K ﹤0.01% 3493
2025
Q3
$586K Buy
+6,000
New +$621K ﹤0.01% 2910
2021
Q4
Sell
-5,000
Closed -$217K 4310
2021
Q3
$217K Buy
+5,000
New +$221K ﹤0.01% 3909
2020
Q4
Sell
-9,600
Closed -$367K 3350
2020
Q3
$367K Buy
+9,600
New +$370K ﹤0.01% 2455
2020
Q1
Sell
-7,300
Closed -$330K 3137
2019
Q4
$330K Sell
7,300
-12,800
-64% -$536K ﹤0.01% 3115
2019
Q3
$818K Sell
20,100
-1,700
-8% -$72K ﹤0.01% 2153
2019
Q2
$937K Buy
+21,800
New +$839K ﹤0.01% 1980
2018
Q2
Sell
-18,000
Closed -$492K 3324
2018
Q1
$492K Buy
+18,000
New +$489K ﹤0.01% 2476
2017
Q1
Sell
-86,400
Closed -$1.87M 2915
2016
Q4
$1.87M Buy
86,400
+60,500
+234% +$1.32M 0.01% 1541
2016
Q3
$616K Buy
+25,900
New +$618K ﹤0.01% 2310
2016
Q1
Sell
-56,000
Closed -$1.03M 2803
2015
Q4
$1.03M Buy
+56,000
New +$1M 0.01% 1478

Other funds holding BSX

Two Sigma Investments's BSX Position: Q1 2026 in Review

Two Sigma Investments increased its Boston Scientific (BSX) stake by 281% in Q1 2026, buying an estimated $555M and bringing the position to 9,411,231 shares worth $591M. The position accounts for 0.48% of the portfolio, ranked #27.

Two Sigma Investments first reported a position in BSX in Q2 2013 and has held it in 44 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Two Sigma Investments held 9,411,231 shares of Boston Scientific worth $591M as of Q1 2026.
  • Two Sigma Investments bought 6,939,887 Boston Scientific shares in Q1 2026, an estimated $555M.
  • Boston Scientific made up 0.48% of Two Sigma Investments's portfolio in Q1 2026, its #27 holding.
  • Two Sigma Investments first reported a position in Boston Scientific in Q2 2013 and has held it in 44 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.